Key result
A multivalent FMD vaccine elicited protective antibody titers and provided up to 100% clinical protection against homologous challenge for 12 months when administered with one or two booster vaccinations.
Why the study?
South Africa experiences sporadic foot and mouth disease outbreaks despite routine cattle vaccination with imported vaccines, which might be mitigated by vaccines prepared from local strains related to those circulating in Kruger National Park buffalo populations.
Does a multivalent FMD vaccine prepared from local virus strains elicit protective immunity in naïve cattle?
Does a multivalent FMD vaccine prepared from local virus strains elicit protective immunity in naïve cattle?
Absolute Event Rate: 100% vs 0%
A multivalent FMD vaccine prepared from local strains can maintain herd immunity in cattle for up to 12 months when administered with booster vaccinations.
May inform FMD vaccination intervals in cattle; leaves open field validation of duration and cross-protection.
South Africa (SA) experiences sporadic foot and mouth disease (FMD) outbreaks irrespective of routine prophylactic vaccinations of cattle using imported commercial vaccines. The problem could be mitigated by preparation of vaccines from local virus strains related to those circulating in the endemically infected buffalo populations in the Kruger National Park (KNP). This study demonstrates the individual number of protective doses (PD) of five vaccine candidate strains after homologous virus challenge, as well as the vaccines safety and onset of humoral immunity in naïve cattle. Furthermore, the duration of post-vaccination immunity over a 12-month period is shown, when a multivalent vaccine prepared from the five strains is administered as a primary dose with or without booster vaccinations. The five monovalent vaccines were shown to contain a 50% PD between 4 and 32, elicit humoral immunity with antibody titers ≥2.0 log10 from day 7 post-vaccination, and cause no adverse reactions. Meanwhile, the multivalent vaccine elicited antibody titers ≥2.0 log10 and clinical protection up to 12 months when one or two booster vaccinations were administered within 6 months of the primary vaccination. An insignificant difference between the application of one or two booster vaccinations was revealed. Owing to the number of PDs, we anticipate that the multivalent vaccine could be used successfully for prophylactic and emergency vaccinations without adjustment of the antigen payloads. Furthermore, a prophylactic vaccination regimen comprising primary vaccination of naïve cattle followed by two booster vaccinations 1.5 and 6 months later could potentially maintain herd immunity over a period of 12 months.
No takes yet. Share an insight, caveat, or question.
Peta et al. (2021) studied Foot and mouth disease (FMD) (n=160). Multivalent FMD vaccine vs. Unvaccinated control was evaluated on Clinical protection post-homologous virus challenge. A multivalent FMD vaccine elicited protective antibody titers and provided up to 100% clinical protection against homologous challenge for 12 months when administered with one or two booster vaccinations.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: